Zachary Contreras of Sharp Health Plan highlighted strategies discussed at AMCP Nexus for improving timely access to ...

Experts discuss dose reduction strategies and emerging therapies for desmoid tumors, emphasizing patient monitoring and ...

Zachary Contreras highlighted strategies discussed at AMCP Nexus for improving timely access to monoclonal migraine receptor ...

The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on ...

Five of 6 baseline health-related social needs (HSRNs) were found to be associated with higher odds of an emergency department visit, leading researchers to encourage health care systems to ...

Leaders from the world of reimbursement explored the complex relationship between payers and providers in oncology, focusing ...

Emergency departments face increased boarding times and uncompensated care burdens, particularly for psychiatric patients.

Oncology leaders warn that declining reimbursements and policy gaps threaten patient access and drive inequities in cancer ...

The top conference coverage published on AJMC.com in 2025 came from several conferences held throughout the year, with ...

On this episode of Managed Care Cast, we’re talking with the co-editors in chief of The American Journal of Managed Care® ( ...